好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A One-hour 好色先生al Session Decreased Subsequent Opioid Prescribing Within an Academic Neurology Department
Practice, Policy, and Ethics
P1 - Poster Session 1 (11:45 AM-12:45 PM)
1-012
We evaluated the effectiveness of a departmental grand rounds about opioid indications, safety, and prescribing guidelines on the opioid prescribing behavior of a large academic neurology department.

The opioid epidemic has highlighted the need for physicians to avoid contributing to opioid use disorder while continuing to offer optimal care for patients with painful conditions. Use of an opioid prescription monitoring tool by a health-system-wide opioid stewardship committee may help identify prescribing patterns and opportunities for increased use of effective non-opioid alternative treatments at the department and individual prescriber levels.

Opioid prescriptions within an academic neurology department were monitored for a five-month period before a one-hour educational grand rounds about opioids, and again for five months after the grand rounds. The top six opioid-prescribing physicians within the department attended the grand rounds and had a 30-minute session with a board-certified pain medicine expert and neurologist to highlight best clinical practices as well as recent national and state prescribing and documentation guidelines for opioid prescriptions

There was a 24% pre-post decrease in total opioid prescriptions by the department, and a 17% pre-post decrease in opioid prescriptions written by the top six prescribers within the department during the 5-month period monitored after the educational session, compared to the 5-month period prior to the educational session.

A one-hour discussion about opioids led to a substantial and sustained decrease in opioid prescribing within a large academic neurology department. Utilization of enterprise-wide outpatient opioid prescription monitoring systems may help identify further educational opportunities to continue addressing the opioid epidemic without compromising patient care.

Authors/Disclosures
Tigran Kesayan, MD (VUMC Pain Medicine and Neurology)
PRESENTER
Dr. Kesayan has nothing to disclose.
David R. Curfman, MD Dr. Curfman has nothing to disclose.
Daniel B. Larach, MD An immediate family member of Dr. Larach has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intuitive Surgical.
Amanda Toye, MD Dr. Toye has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics Information Technology.
Jennifer M. Slayton, RN, DNP Dr. Slayton has nothing to disclose.
Carin McAbee, MA Ms. McAbee has nothing to disclose.
Kelly M. Brown, MD (Vanderbilt University) An immediate family member of Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. An immediate family member of Dr. Brown has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Swan. The institution of an immediate family member of Dr. Brown has received research support from Sirtex.
Hayley Rector, PharmD Dr. Rector has nothing to disclose.
Elizabeth Huggins (Vanderbilt University Medical Center) Elizabeth Huggins has nothing to disclose.
Tyler W. Barrett, MD MSCI, MD Dr. Barrett, MD MSCI has nothing to disclose.
Tyler W. Barrett, MD MSCI, MD Dr. Barrett, MD MSCI has nothing to disclose.
Dane M. Chetkovich, MD, PhD, FAAN (Vanderbilt University Medical Center) Dr. Chetkovich has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Legal Matters. The institution of Dr. Chetkovich has received research support from NIH. Dr. Chetkovich has a non-compensated relationship as a committee service member with ABPN that is relevant to AAN interests or activities.